TerminatedPHASE2, PHASE3NCT00581477

Treatment of Orthostatic Hypotension

Studying Dopamine beta-hydroxylase deficiency

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Vanderbilt University
Principal Investigator: David Robertson, MD
Vanderbilt University
Intervention: Droxidopa Oral Product(drug)
Enrollment: 8 enrolled
Eligibility: 18-70 years · All sexes
Timeline: 2004 – 2020

Study locations (1)

Vanderbilt University, Nashville, Tennessee, United States

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00581477 on ClinicalTrials.gov

← Back to all trials